Aristopharma Ltd

News

 

Aristopharma has launched Arthanib & Arthanib XR Tablet for Rheumatoid Arthritis

Aristopharma has launched Arthanib & Arthanib XR Tablet for Rheumatoid Arthritis (RA) patients. A substantial proportion of RA patients do not achieve proper disease control and discontinue therapy due to therapeutic resistance or adverse events when treated with conventional DMARDs like methotrexate or sulfasalazine.

Tofacitinib is an USFDA approved Janus Kinase (JAK) inhibitor which is effective and safe in the treatment of RA & thus provides a new hope for these patients.